The natural interleukin-1 receptor antagonist prevents interleukin-l-induced preterm delivery in mice
- 1 October 1992
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 167 (4), 1041-1045
- https://doi.org/10.1016/s0002-9378(12)80035-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.JCI Insight, 1992
- A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.The Journal of Experimental Medicine, 1991
- Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.The Journal of Experimental Medicine, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.JCI Insight, 1990
- Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist proteinNature, 1990
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).JCI Insight, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985